Abstract
Validation is essential for the translation of newly developed alternative approaches to animal testing into tools and solutions suitable for regulatory applications. Formal approaches to validation have emerged over the past 20 years or so and although they have helped greatly to progress the field, it is essential that the principles and practice underpinning validation continue to evolve to keep pace with scientific progress. The modular approach to validation should be exploited to encourage more innovation and flexibility in study design and to increase efficiency in filling data gaps. With the focus now on integrated approaches to testing and assessment that are based on toxicological knowledge captured as adverse outcome pathways, and which incorporate the latest in vitro and computational methods, validation needs to adapt to ensure it adds value rather than hinders progress. Validation needs to be pursued both at the method level, to characterise the performance of in vitro methods in relation their ability to detect any association of a chemical with a particular pathway or key toxicological event, and at the methodological level, to assess how integrated approaches can predict toxicological endpoints relevant for regulatory decision making. To facilitate this, more emphasis needs to be given to the development of performance standards that can be applied to classes of methods and integrated approaches that provide similar information. Moreover, the challenge of selecting the right reference chemicals to support validation needs to be addressed more systematically, consistently and in a manner that better reflects the state of the science. Above all however, validation requires true partnership between the development and user communities of alternative methods and the appropriate investment of resources.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arnold SF, Robinson MK, Notides AC, Guillette LJ, McLachlan JÁ (1996) A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environ Health Perspect 104(5):544–548
Balls M, Blaauboer B, Brusick D, Frazier J, Lamb D, Pemberton M, Reinhardt C, Roberfroid M, Rosenkranz H, Schmid B, Spielmann H, Stammati A-L, Walum E (1990) Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. Altern Lab Anim 18:313–337
Bouhifd M, Bories G, Casado J, Coecke S, Norlén H, Parissis N, Rodrigues R, Whelan M (2012) Automation of an in vitro cytotoxicity assay used to estimate starting doses in acute oral systemic toxicity tests. Food Chem Toxicol 50:2084–2096
Brown NA (2002) Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods. Altern Lab Anim 30(2):177–198
Browne P, Judson R, Casey W, Kleinstreuer N, Thomas R (2015) Screening chemicals for estrogen receptor bioactivity using a computational model. Environ Sci Technol 49(14):8804–8814
Casati S, Aeby P, Kimber I, Maxwell G, Ovigne JM, Roggen E, Rovida C, Tosti L, Basketter D (2009) Selection of chemicals for the development and evaluation of in vitro methods for skin sensitisation testing. Altern Lab Anim 37(3):305–312
CLP (2008) Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006
EFSA (2015) EFSA Scientific Committee Opinion: draft guidance on uncertainty in EFSA scientific assessment, European Food Safety Authority (EFSA), Parma, Italy
Eskes C, Cole T, Hoffmann S, Worth A, Cockshott A, Gerner I, Zuang V (2007) The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals. Altern Lab Anim 35:1–17
GHS (2015) Globally harmonized system of classification and labelling of chemicals (GHS)—Sixth revised edition United Nations Economic Commission for Europe (UNECE). http://www.unece.org/trans/danger/publi/ghs/ghs_rev06/06files_e.html#c38156
Hartung T, Bremer S, Casati S, Coecke S, Corvi R, Fortaner S, Gribaldo L, Halder M, Hoffmann S, Roi AJ, Prieto P, Sabbioni E, Scott L, Worth A, Zuang V (2004) A modular approach to the ECVAM principles on test validity. Altern Lab Anim 32:467–472
Huang R, Xia M, Sakamuru S, Zhao J, Shahane SA, Attene-Ramos M, Zhao T, Austin CP, Simeonov A (2016) Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization. Nat Commun 7:10425
Jennings P, Schwarz M, Landesmann B, Maggioni S, Goumenou M, Bower D, Leonard MO, Wiseman JS (2014) SEURAT-1 liver gold reference compounds: a mechanism-based review. Arch Toxicol 88(12):2099–2133
Judson R, Kavlock R, Martin M, Reif D, Houck K, Knudsen T, Richard A, Tice RR, Whelan M, Xia M, Huang R, Austin C, Daston G, Hartung T, Fowle JR 3rd, Wooge W, Tong W, Dix D (2013) Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. ALTEX 30(1):51–56
Judson R, Houck K, Martin M, Knudsen T, Thomas R, Sipes N, Shah I, Wambaugh J, Crofton K (2014) In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme. Basic Clin Pharmacol Toxicol 115(1):69–76
Judson R, Magpantay F, Chickarmane V, Haskell C, Tania N, Taylor J, Xia M, Huang R, Rotroff D, Filer D, Houck K, Martin M, Sipes N, Richard A, Mansouri K, Setzer W, Knudsen T, Crofton K, Thomas R (2015) Integrated model of chemical perturbations of a biological pathwayusing 18 in vitro high throughput screening assays for the estrogen receptor. Toxicological Sciences, Society of Toxicology, pp. 1–42
Kinsner-Ovaskainen A, Maxwell G, Kreysa J, Barroso J, Adriaens E, Alépée N, Berg N, Bremer S, Coecke S, Comenges JZ, Corvi R, Casati S, Dal Negro G, Marrec-Fairley M, Griesinger C, Halder M, Heisler E, Hirmann D, Kleensang A, Kopp-Schneider A, Lapenna S, Munn S, Prieto P, Schechtman L, Schultz T, Vidal JM, Worth A, Zuang V (2012) Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS). Altern Lab Anim 40(3):175–181
Kirkland D, Kasper P, Martus HJ, Müller L, van Benthem J, Madia F, Corvi R (2016) Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests. Mutat Res Genet Toxicol Environ Mutagen 795(2016):7–30
Kleinstreuer NC, Ceger PC, Allen DG, Strickland J, Chang X, Hamm JT, Casey WM (2016) A curated database of rodent uterotrophic bioactivity. Environ Health Perspect 124(5):556–562. doi:10.1289/ehp.1510183
OECD (2005) Guidance Document No.34: The validation and international acceptance of new or updated test methods for hazard assessment, OECD Series on Testing and Assessment. Organization for Economic Cooperation and Development, Paris
OECD (2012a) Test No. 455: Performance-based test guideline for stably transfected transactivation in vitro assays to detect estrogen receptor agonists, OECD guidelines for the testing of chemicals, section 4, OECD Publishing, Paris. doi:10.1787/9789264185388-en
OECD (2012b), Performance Standards No. 173: Performance standards for stably transfected transactivation in vitro assays to detect estrogen agonists for TG 455. OECD Series on Testing and Assessment, OECD Publishing, Paris
OECD (2014a) Guidance document on integrated approaches to testing and assessment of skin irritation/corrosion. Series on Testing and Assessment, No. 203, OECD, Paris
OECD (2014b) Guidance Document No. 211: Guidance document for describing non-guideline in vitro test methods. Series on Testing and Assessment, OECD Publishing, Paris
OECD (2016) Guidance Document on the Reporting of Defined Approaches to be used within Integrated Approaches to Testing and Assessment, Task Force on Hazard Assessment. Draft January 2016
Pazos P, Pellizzer C, Stummann T, Hareng L, Bremer S (2010) The test chemical selection procedure of the European Centre for the Validation of Alternative Methods for the EU Project ReProTect. Reprod Toxicol 30(1):161–199
RAAF (2015) Read across assessment framework. European Chemicals Agency, Helsinki, http://echa.europa.eu/documents/10162/13628/raaf_en.pdf
REACH (2006) Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC
WHO (2014) Guidance document on evaluating and expressing uncertainty in hazard characterization, WHO International Programme on Chemical Safety: Harmonization Project Document No.11. http://www.who.int/ipcs/methods/harmonization/uncertainty_in_hazard_characterization.pdf
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Whelan, M., Eskes, C. (2016). Evolving the Principles and Practice of Validation for New Alternative Approaches to Toxicity Testing. In: Eskes, C., Whelan, M. (eds) Validation of Alternative Methods for Toxicity Testing. Advances in Experimental Medicine and Biology, vol 856. Springer, Cham. https://doi.org/10.1007/978-3-319-33826-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-33826-2_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33824-8
Online ISBN: 978-3-319-33826-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)